# Safety of Engensis in Participants With Amyotrophic Lateral Sclerosis

> **NCT04632225** · PHASE2 · COMPLETED · sponsor: **Helixmith Co., Ltd.** · enrollment: 18 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **BIOLOGICAL:** Engensis
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04632225
- **Lead sponsor:** Helixmith Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-09
- **Primary completion:** 2022-07-11
- **Final completion:** 2024-07-15
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04632225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04632225, "Safety of Engensis in Participants With Amyotrophic Lateral Sclerosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04632225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*